project . 2016 - 2018 . Closed


Open Access mandate for Publications
European Commission
Funder: European CommissionProject code: 692293 Call for proposal: H2020-TWINN-2015
Funded under: H2020 | CSA Overall Budget: 999,475 EURFunder Contribution: 999,475 EUR
Status: Closed
01 Jan 2016 (Started) 31 Dec 2018 (Ended)
Open Access mandate
Research data: No

The objective of this Twinning project is to significantly strengthen the research in Riga Stradins University (RSU; Latvia) in the smart specialization area of Latvia “bio-medicine, medical technologies, and biotechnologies” with application to immunotherapy of cancer through building an up-rising connections with two internationally leading research institutions, Institute of Microbiology, Tumor and Cell Biology, Karolinska Institutet (Sweden) and the Department of General Biophysics, University of Lodz (Poland). Both represent centers of excellence in the design, testing and clinical applications of a wide class of immunotherapeuticals, with focus on technologies exploiting naked nucleic acids.

Data Management Plans